PHS
PFM Health Sciences Portfolio holdings
AUM
$1.15B
This Quarter Return
-3.88%
1 Year Return
+21.39%
3 Year Return
+130.75%
5 Year Return
+265.32%
10 Year Return
+1,236.5%
AUM
$1.31B
AUM Growth
+$1.31B
(-25%)
Cap. Flow
-$296M
Cap. Flow
% of AUM
-22.54%
Top 10 Holdings %
Top 10 Hldgs %
50.96%
Holding
96
New
18
Increased
9
Reduced
25
Closed
19
Top Buys
| 1 |
DexCom
DXCM
|
$25.6M |
| 2 |
Neurocrine Biosciences
NBIX
|
$22.8M |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
$21.7M |
| 4 |
Invesco S&P 500 Equal Weight ETF
RSP
|
$18.9M |
| 5 |
United Therapeutics
UTHR
|
$18.5M |
Top Sells
| 1 |
Cytokinetics
CYTK
|
$92.8M |
| 2 |
Merck
MRK
|
$61.6M |
| 3 |
Acadia Healthcare
ACHC
|
$43.5M |
| 4 |
Elevance Health
ELV
|
$29.3M |
| 5 |
Amgen
AMGN
|
$29.1M |
Sector Composition
| 1 | Healthcare | 92.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Biohaven
BHVN
$1.71B
| $16.1M | 1% |
+431,916
| New | +$16.1M |
|
27
Soleno Therapeutics
SLNO
$3.56B
| $13.8M | 0.86% |
+307,503
| New | +$13.8M |
|
28
Sarepta Therapeutics
SRPT
$1.98B
| $12.2M | 0.75% |
100,172
+11,956
| +14% | +$1.45M |
|
29
Stryker
SYK
$149B
| $11.6M | 0.72% |
32,349
-34,665
| -52% | -$12.5M |
|
30
Veeva Systems
VEEV
$44.4B
| $11.6M | 0.72% |
55,383
+36,124
| +188% | +$7.6M |
|
31
Oscar Health
OSCR
$4.57B
| $11.6M | 0.72% |
860,821
| – | – |
|
32
Health Care Select Sector SPDR Fund
XLV
$33.8B
| $11.5M | 0.71% |
+83,806
| New | +$11.5M |
|
33
Erasca
ERAS
$406M
| $11M | 0.68% |
4,390,427
-486,484
| -10% | -$1.22M |
|
34
Thermo Fisher Scientific
TMO
$183B
| $10.9M | 0.68% |
21,040
-37,393
| -64% | -$19.5M |
|
35
Praxis Precision Medicines
PRAX
$980M
| $9.2M | 0.57% |
119,509
-63,583
| -35% | -$4.89M |
|
36
Centene
CNC
$14.8B
| $8.75M | 0.54% |
+144,501
| New | +$8.75M |
|
37
Teva Pharmaceuticals
TEVA
$21.5B
| $8.75M | 0.54% |
+397,024
| New | +$8.75M |
|
38
BridgeBio Pharma
BBIO
$9.91B
| $7.96M | 0.49% |
+290,242
| New | +$7.96M |
|
39
SPDR S&P 500 ETF Trust
SPY
$656B
| $7.28M | 0.45% |
+12,427
| New | +$7.28M |
|
40
Ascendis Pharma
ASND
$12.1B
| $7.21M | 0.45% |
52,392
-38,374
| -42% | -$5.28M |
|
|
CNTA
41
Centessa Pharmaceuticals
CNTA
$2.13B
| $6.23M | 0.39% |
371,766
+102,608
| +38% | +$1.72M |
|
42
Caribou Biosciences
CRBU
$176M
| $6.16M | 0.38% |
3,876,462
-430,209
| -10% | -$684K |
|
43
KraneShares CSI China Internet ETF
KWEB
$8.51B
| $5.29M | 0.33% |
+180,974
| New | +$5.29M |
|
44
uniQure
QURE
$954M
| $5M | 0.31% |
283,158
+161,530
| +133% | +$2.85M |
|
45
Xenon Pharmaceuticals
XENE
$2.99B
| $4.59M | 0.28% |
116,998
-62,880
| -35% | -$2.46M |
|
46
Arcellx
ACLX
$3.95B
| $4.34M | 0.27% |
56,603
-3,999
| -7% | -$307K |
|
47
Werewolf Therapeutics
HOWL
$62.6M
| $4.3M | 0.27% |
2,905,465
-493,282
| -15% | -$730K |
|
48
BioNTech
BNTX
$24.1B
| $3.77M | 0.23% |
+33,109
| New | +$3.77M |
|
|
BPMC
49
DELISTED
Blueprint Medicines
BPMC
| $3.74M | 0.23% |
+42,840
| New | +$3.74M |
|
|
ITCI
50
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $3.39M | 0.21% |
40,610
-36,777
| -48% | -$3.07M |
|